| Publications |
Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. 2011. The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunol Immunother. Feb 22, 2011. (Epub ahead of print)
Yang RK, Sondel PM. 2010. Anti-GD2 Strategy in the Treatment of Neuroblastoma (review). Drugs Future 35:665.
Delgado DC, Hank JA, Kolesar J, Lorentzen D, Gan J, Seo S, Kim K, Shusterman S, Gillies SD, Reisfeld RA, Yang RK, Gadbaw B, DeSantes KB, London WB, Seeger RC, Maris JM, Sondel PM. 2010. Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer Res 70:9554-61.
|
